Oramed Pharmaceuticals Inc. (FRA:OJU1)

Oramed Pharmaceuticals Statistics

Total Valuation

FRA:OJU1 has a market cap or net worth of EUR 97.83 million. The enterprise value is -18.41 million.

Market Cap	97.83M
Enterprise Value	-18.41M

Important Dates

The next estimated earnings date is Thursday, March 5, 2026.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	39.80M
Shares Outstanding	n/a
Shares Change (YoY)	+3.29%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	13.27%
Owned by Institutions (%)	10.76%
Float	31.35M

Valuation Ratios

The trailing PE ratio is 2.62.

PE Ratio	2.62
Forward PE	n/a
PS Ratio	57.39
PB Ratio	0.57
P/TBV Ratio	0.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.49
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2.04

Financial Position

The company has a current ratio of 22.24, with a Debt / Equity ratio of 0.00.

Current Ratio	22.24
Quick Ratio	22.08
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.48% and return on invested capital (ROIC) is -4.53%.

Return on Equity (ROE)	24.48%
Return on Assets (ROA)	-4.22%
Return on Invested Capital (ROIC)	-4.53%
Return on Capital Employed (ROCE)	-6.07%
Revenue Per Employee	426,150
Profits Per Employee	9.34M
Employee Count	4
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:OJU1 has paid 10.17 million in taxes.

Income Tax	10.17M
Effective Tax Rate	21.41%

Stock Price Statistics

The stock price has increased by +14.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.24%
50-Day Moving Average	2.07
200-Day Moving Average	1.97
Relative Strength Index (RSI)	69.42
Average Volume (20 Days)	382

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.50

Income Statement

In the last 12 months, FRA:OJU1 had revenue of EUR 1.70 million and earned 37.38 million in profits. Earnings per share was 0.88.

Revenue	1.70M
Gross Profit	11,080
Operating Income	-11.09M
Pretax Income	47.51M
Net Income	37.38M
EBITDA	-10.99M
EBIT	-11.09M
Earnings Per Share (EPS)	0.88

Balance Sheet

The company has 114.79 million in cash and 732,978 in debt, giving a net cash position of 114.06 million.

Cash & Cash Equivalents	114.79M
Total Debt	732,978
Net Cash	114.06M
Net Cash Per Share	n/a
Equity (Book Value)	172.45M
Book Value Per Share	4.24
Working Capital	110.80M

Cash Flow

In the last 12 months, operating cash flow was -9.03 million and capital expenditures -15,341, giving a free cash flow of -9.04 million.

Operating Cash Flow	-9.03M
Capital Expenditures	-15,341
Free Cash Flow	-9.04M
FCF Per Share	n/a

Margins

Gross margin is 0.65%, with operating and profit margins of -650.55% and 2,192.60%.

Gross Margin	0.65%
Operating Margin	-650.55%
Pretax Margin	2,787.20%
Profit Margin	2,192.60%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:OJU1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.29%
Shareholder Yield	-3.29%
Earnings Yield	38.20%
FCF Yield	-9.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 23, 2013. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Jan 23, 2013
Split Type	Reverse
Split Ratio	0.0833333333

Scores

FRA:OJU1 has an Altman Z-Score of 2.8 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.8
Piotroski F-Score	1